Search Results - "Baer, Philip"

Inconsistencies in the 2017 Canadian Guideline for Opioids for Chronic Noncancer Pain by Weinberg, Erica L, Baer, Philip A

“…With the 2017 Canadian Guideline for Opioids for Chronic Noncancer Pain (the guideline) currently undergoing an independent assessment of the rigour that went…”
Get full text

A Canadian Retrospective Chart Review Evaluating Concomitant Methotrexate De-escalation Patterns in Patients with Rheumatoid Arthritis Treated with Biologic or Targeted Synthetic DMARDs by Bessette, Louis, Florica, Brandusa, Naik, Latha, Sholter, Dalton, Fournier, Pierre-André, Girard, Tanya, Liazoghli, Dalinda, Baer, Philip A.

“…Introduction Rheumatoid arthritis (RA) guidelines recommend methotrexate (MTX)-anchored therapy with biologic or targeted synthetic disease-modifying…”
Get full text

The incidence of giant cell arteritis in Ontario, Canada by Ing, Edsel B., Lahaie Luna, Gabriela, Pagnoux, Christian, Baer, Philip A., Wang, Dani, Benard-Seguin, Etienne, Godra, Ishan, Godra, Anita, Munoz, David G., McReelis, Kylen, ten Hove, Martin

“…The incidence of giant cell arteritis (GCA) is insufficiently documented for Canada, but important to ascertain for public health planning. We estimate the…”
Get full text

Treatment of osteoarthritis of the knee with a topical diclofenac solution: a randomised controlled, 6-week trial [ISRCTN53366886] by Baer, Philip A, Thomas, Lisa M, Shainhouse, Zev

“…Topical NSAIDs have been proven to relieve the symptoms of osteoarthritis (OA) in short-term studies (2 weeks). To justify its chronic use, efficacy of a…”
Get full text

Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis by Ogdie, Alexis, de Vlam, Kurt, McInnes, Iain B, Mease, Philip J, Baer, Philip, Lukic, Tatjana, Gruben, David, Kwok, Kenneth, Wang, Cunshan, Hsu, Ming-Ann, Maniccia, Anna

“…ObjectiveTo describe the efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA) or ankylosing…”
Get full text

Generic controlled-release oxycodone by Baer, Philip A, Bordman, Joel, Weinberg, Erica L

“…We wish to respond to [Miller A. Aglukkaq]'s article in CMAJ.1 The US Food and Drug Administration (FDA) approved abuse-deterrent labelling for reformulated…”
Get full text

Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry by Rahman, Proton, Baer, Philip, Keystone, Ed, Choquette, Denis, Thorne, Carter, Haraoui, Boulos, Chow, Andrew, Faraawi, Rafat, Olszynski, Wojciech, Kelsall, John, Rampakakis, Emmanouil, Lehman, Allen J, Nantel, Francois

“…Long-term clinical registries are essential tools to evaluate new therapies in a patient population that differs from those in randomized clinical trials. The…”
Get full text

Patterns and predictors of long-term retention of inflammatory bowel or rheumatoid disease patients on innovator infliximab: an analysis of a Canadian prescriptions claims database by Baer, Philip A, Aumais, Guy, Ewara, Emmanuel M, Khraishi, Majed, Marrache, A Marilise, Panaccione, Remo, Wade, John P, Marshall, John K

“…Long-term effectiveness is an important factor when considering treatment decisions. To determine the long-term retention patterns of Canadian inflammatory…”
Get full text

Patterns and predictors of long-term retention of inflammatory bowel or rheumatoid disease patients on innovator infliximab: an analysis of a Canadian prescriptions claims database [Erratum] by Baer, Philip A, Aumais, Guy, Ewara, Emmanuel M, Khraishi, Majed, Marrache, A Marilise, Panaccione, Remo, Wade, John P, Marshall, John K

“…Baer PA, Aumais G, Ewara EM, et al. Patient Prefer Adherence. 2018;12:1805-1814.On page 1805, the affiliations were incorrectly listed.Read the original article…”
Get full text

Oxford Textbook of Musculoskeletal Medicine (2nd Edition) by BAER, PHILIP A.

Get full text

Regional hemodynamic effects of the N-(2-benzoylphenyl)-L-tyrosine peroxisome proliferator-activated receptor-gamma ligand, GI 262570 [(S)-2-(2-benzoylphenylamino)-3-[4-[2-(5-methyl-2-phenyl-2-oxazol-4-yl)ethoxy]phenyl]propionic acid], in conscious rats by Gardiner, Sheila M, Nunez, Derek J R, Baer, Philip G, Brown, Kathleen K, Bennett, Terence

“…This study provides novel data on the regional hemodynamic effects of the peroxisome proliferator-activated receptor-gamma activator, GI 262570…”
Get more information

Effects of a PPARγ Agonist, GI262570, on Renal Filtration Fraction and Nitric Oxide Level in Conscious Rats by Yang, Baichun, Clifton, Lisa G, McNulty, Judi A, Chen, Lihong, Brown, Kathleen K, Baer, Philip G

“…PPARγ agonists ameliorate insulin resistance and lower blood pressure. Volume expansion/edema has been observed in susceptible patients treated with these…”
Get full text

3-[4-(1,2-Diphenylbut-1-enyl)phenyl]acrylic Acid: A Non-Steroidal Estrogen with Functional Selectivity for Bone over Uterus in Rats by Willson, Timothy M, Henke, Brad R, Momtahen, Tanya M, Charifson, Paul S, Batchelor, Kenneth W, Lubahn, Dennis B, Moore, Linda B, Oliver, Beverly B, Sauls, Howard R, Triantafillou, James A, Wolfe, Steven G, Baer, Philip G

Get full text

Biphasic urethral sphincter responses to acetic acid infusion into the lower urinary tract in anesthetized cats by Chen, Z, Anderson, D L, Faison, W L, Baer, P G

“…Varying the concentration of infused acetic acid produced bladder irritation and dose dependent increases in external urethral sphincter electromyography…”
Get more information

Real-world validation of the minimal disease activity index in psoriatic arthritis: an analysis from a prospective, observational, biological treatment registry by Rahman, Proton, Zummer, Michel, Bessette, Louis, Baer, Philip, Haraoui, Boulos, Chow, Andrew, Kelsall, John, Kapur, Suneil, Rampakakis, Emmanouil, Psaradellis, Eliofotisti, Lehman, Allen J, Nantel, Francois, Osborne, Brendan, Tkaczyk, Cathy

“…ObjectiveTo describe the minimal disease activity (MDA) rate over time in patients with psoriatic arthritis (PsA) receiving antitumour necrosis factor agents,…”
Get full text

Estimation of tuberculosis incidence at subnational level using three methods to monitor progress towards ending TB in India, 2015–2020 by Thangaraj, Jeromie, Rade, Kiran, Modi, Bhavesh, Selvaraju, Sriram, Velusamy, Saravanakumar, Akhil, Sasidharan, Sudha Rani, Dhanapal, Manikandanesan, Sakthivel, Elumalai, Rajalakshmi, Natarajan, Meenakumari, Mahapatra, Amarendra, Sridhar, Anand, Chowdhury, Aniket, Shafie, Asif, Choudhury, Avijit, Dhrubjyoti, Deka, Sirmanwar, Krushna, Khaparde, Kshitij, Ahmed, Quazi, Prasad, Ranjeet, Shinde, Rohini, Baruah, Rupali, Achanta, Shanta, Sharath, Burugina Nagaraja, Balakrishnan, Shibu, Chandra, Shivani, Khumukcham, Sophia, Mandal, Sudarsan, Rao, Raghuram, Sachdeva, Kuldeep, Murhekar, Manoj, Kurada, Jayakrishna, Sharma, Mayank, Mannan, Shamim, Thekkepat, Sapna, Kumaraswamy, Karthikeyan, Tharakan, Mallika, Majumdar, Shramana, Mahajan, Swati, Waikar, Shekhar, Ambule, Puja, Bhimarasetty, Devi Madhavi, Bhrahmbhatt, Krutarth, Modi, Bhautik, Gupta, Anmol, Raina, Sunil, Gupta, Rajiv Kumar, Sinha, Ratnesh, Toppo, Manju, Sankhe, Lalit, Medhi, Gajen, Patki, Swati M, Das, Bishnu Ram, Sarangi, Lisa, Sharma, Sarit, Hakim, Afsal, Balan, Suresh, Baidya, Subrata, Sinha, Abhik, Naidu, Boddepalli Nagendra, Nayak, Bikash Chandra, Boro, Pallavi, Sarkar, Amrita, Bariya, Bhavesh, Mehta, Paras, Chhaya, Jatin, Thakor, Nilesh, Ram, Rohit, Banerjee, Anupam, Sood, Abhilash, Dolma, Yangchen, Bahl, Rakesh, Singh, Surinder, Kumar, Dilip, Jayasree, A K, Haveri, Sheela P, Marskole, Priyesh, Verma, Prashant, Pal, Dinesh Kumar, Toppo, Neelam, Quraishi, Sanjay R, Gothankar, Jayashree, Kadam, Swapnali S, Rao, Dasi, Singh, Vijay, Wanje, Sudhir, Devi, Ningombam Joenna, Marak, Rikrak Ch, Lyngdoh, Markordor, Patki, Manoj B, Ray, Satyajit Sundar, Vasudevan, Kavita, Kaur, Jasleen, Choudhary, Mahesh, Parmar, Mitin, Govindasamy, Venkatesh, Mog, Chanda, Singh, Ritesh, Maity, Chandra Shekar, Gehlawat, Mamta

“…ObjectivesWe verified subnational (state/union territory (UT)/district) claims of achievements in reducing tuberculosis (TB) incidence in 2020 compared with…”
Get full text

Introduction of a conformational switching element on a pyrrolidine ring. Synthesis and evaluation of methyl (R,R)-(.+-.)-3-acetyl-4-[3- (cyclopentyloxy)-4-methoxyphenyl]-3- methyl-1-pyrrolidinecarboxylate, a potent and selective inhibitor of cAMP-specific phosphodiesterase by Stafford, Jeffrey A, Veal, James M, Feldman, Paul L, Valvano, Nicole L, Baer, Philip G, Brackeen, Marcus F, Brawley, E. Sloan, Connolly, Kevin M, Domanico, Paul L

Get full text

Canadian Recommendations for Use of Methotrexate in Patients with Rheumatoid Arthritis by KATCHAMART, Wanruchada, BOURRE-TESSIER, Josiane, SHOJANIA, Kam, THOMSON, John, THORNE, J. Carter, BOMBARDIER, Claire, DONKA, Timea, DROUIN, Julie, ROHEKAR, Gina, BYKERK, Vivian P, HARAOUI, Boulos, LECLERQ, Sharon, MOSHER, Dianne P, POPE, Janet E

“…To develop recommendations for the use of methotrexate (MTX) in patients with rheumatoid arthritis. Canadian rheumatologists who participated in the…”
Get full text

Vasopressor Hyperresponsiveness in New Zealand Genetically Hypertensive Rats by BAER, PHILIP G

“…The relationship of blood pressure (BP) to vascular hyperresponsiveness to norepinephrine (NE) in New Zealand genetically hypertensive (NZGH) rats was studied…”
Get full text

Platelet Activating Factor Vasoconstriction of Dog Kidney Inhibition by Alprazolam by BAER, PHILIP G, CAGEN, LAUREN M

“…Systemic administration of platelet activating factor (PAF; acetyl glyceryl ether phosphorylcholine) reduces renal blood flow, but the mechanism responsible…”
Get full text